Medium-chain triglycerides may improve memory in non-demented older adults: a systematic review of randomized controlled trials - PubMed (original) (raw)

Medium-chain triglycerides may improve memory in non-demented older adults: a systematic review of randomized controlled trials

Panagiotis Giannos et al. BMC Geriatr. 2022.

Abstract

Background: Ketosis has been exploited for its neuroprotective impact and treatment of neurological conditions via ketone production. Exogenous medium-chain triglyceride (MCT) supplementation may induce nutritional ketosis. The aim of this systematic review is to explore the effects of MCTs on memory function in older adults without cognitive impairment.

Methods: A systematic literature search of PubMed, Cochrane Library, Scopus, and Web of Science was employed from inception until April 2022 for randomized controlled trials (RCTs) in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, investigating the impact of MCT oils on components of memory. Risk of bias (RoB2) tool was utilized for quality assessment.

Results: Six trials were included for qualitative synthesis, in which two studies examined the effect of MCTs through a ketogenic meal. MCT supplementation compared to controls was associated with improved indices of memory function in 4 out of 6 studies, particularly working memory. A meta-analysis was not employed due to the low number of studies, therefore, a true effect measure of MCT supplementation was not explored.

Conclusions: MCT supplementation may enhance working memory in non-demented older adults. These effects may be more prominent in individuals with lower baseline scores, from short and long-term supplementation. Further studies are warranted to confirm these findings in terms of optimal dose and MCTs composition, which may protect from memory decline during aging.

Keywords: Cognitive function; Medium-chain triglycerides; Memory; Non-demented; Nutritional ketosis.

© 2022. The Author(s).

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Fig. 1

Fig. 1

Flowchart of the employed literature search

Fig. 2

Fig. 2

Risk of bias assessment of the included studies

Similar articles

Cited by

References

    1. Prasoppokakorn T, Jirasakuldej S, Lakananurak N. Medium-chain triglyceride ketogenic diet is effective for treatment of an adult with super-refractory status epilepticus: a case report and literature review. Eur J Clin Nutr. 2019;73:1594–1597. doi: 10.1038/s41430-019-0471-4. - DOI - PubMed
    1. Kovács Z, Brunner B, Ari C. Beneficial Effects of Exogenous Ketogenic Supplements on Aging Processes and Age-Related Neurodegenerative Diseases. Nutrients. 2021;13:2197. doi: 10.3390/nu13072197. - DOI - PMC - PubMed
    1. Vandenberghe C, St-Pierre V, Fortier M, Castellano C-A, Cuenoud B, Cunnane SC. Medium chain triglycerides modulate the ketogenic effect of a metabolic switch. Front Nutr. 2020;7:3. doi: 10.3389/fnut.2020.00003. - DOI - PMC - PubMed
    1. Cunnane SC, Courchesne-Loyer A, St-Pierre V, Vandenberghe C, Pierotti T, Fortier M, Croteau E, Castellano CA. Can ketones compensate for deteriorating brain glucose uptake during aging? Implications for the risk and treatment of Alzheimer's disease. Ann N Y Acad Sci. 2016;1367:12–20. doi: 10.1111/nyas.12999. - DOI - PubMed
    1. Roopashree P, Shetty SS, Kumari NS. Effect of medium chain fatty acid in human health and disease. J Funct Foods. 2021;87:104724. doi: 10.1016/j.jff.2021.104724. - DOI

Publication types

MeSH terms

Substances

LinkOut - more resources